MADISON, Wis.--(BUSINESS WIRE)--BioForward Wisconsin, the collective voice of Wisconsins robust and comprehensive biohealth cluster, representing more than 220 member organizations, has announced the winners of the sixth annual Wisconsin Biohealth Awards.
These awards showcase leadership and innovation in the Wisconsin biohealth industry and specifically recognize scientific and business successes that have brought Wisconsin to be leaders in integrated health solutions.
The 2020 winners of the Hector F. DeLuca Scientific Achievement Award is Dr. Mary Horowitz, and Wisconsin Biohealth Business Achievement Award is Dr. Jim Weber.
Dr. Mary Horowitz is an active blood and marrow transplant physician whose research and dedication to the field of stem cell transplant and hematologic malignancy practice has had a significant impact worldwide. Dr. Horowitz joined the Center for International Blood and Marrow Transplant Research (CIBMTR) in 1985 and has served as its Chief Scientific Director since 1991. Dr. Horowitz is also the Research Director for the Stem Cell Therapeutic Outcomes Database of the C.W. Bill Young Cell Transplantation Program and Principal Investigator of the Data and Coordinating Center of the National Blood and Marrow Transplant Clinical Trials Network. She holds the Robert A. Uihlein Professorship for Hematologic Research at Medical College of Wisconsin and has previously served as Chief of the Division of Hematology and Oncology in MCWs Department of Medicine. Dr. Horowitz has served on numerous NIH review and advisory committees and has been continuously funded by the NIH since 1991. She has co-authored more than 400 peer-reviewed publications.
Dr. James Weber founded PreventionGenetics in 2004 with a vision of "disease prevention through genetic testing." An internationally acclaimed research scientist, Dr. Weber was a major contributor to The Human Genome Project. His discovery of Short Tandem Repeat Polymorphisms (microsatellites) and the creation of the Marshfield Maps of the human genome was a significant advance in human genetics. He has authored or co-authored more than 200 peer-reviewed scientific publications. In 1986, Dr. Weber joined Marshfield Clinic Research Foundation where he was senior research scientist, director of the Center for Medical Genetics and Director of the National Institutes of Health-funded Mammalian Genotyping Service.
"BioForward Wisconsin is excited and honored to announce this year's award winners," said Lisa Johnson, CEO of BioForward. "Dr. Horowitz and Dr. Weber embody the ideal candidate for these awards due to their globally recognized research achievements that have lead to major medical advances in treating diseases and improving health outcomes. These awards are a testament to the ingenuity, passion, and vision of our awardees."
Wisconsin Biohealth Summit, now in a virtual format over September 23, September 30, and October 7, 2020, will reflect the resilience and creativity of the Wisconsin Biohealth Industry. This years award ceremony will be pre-recorded to allow for the full safety of the awardees but will be featured October 7th a viewing party inviting all attendees to celebrate and honor Dr. Horowitz and Dr. Weber.
The Wisconsin Biohealth Summit sponsors include Tommy G. Thompson Center on Public Leadership, ThermoFisher Scientific, Catalent, Exact Sciences, GE Healthcare, Mallinckrodt, WARF, AbbVie, Aurora Health Care, Cellular Dynamics International, Covance, Findorff, Illumina, Isthmus Project, Kraemer Brothers, PhRMA, PPD, Promega, TeraMedica, University Research Park, and Yahara Software.
To learn more about BioForwards annual Wisconsin Biohealth Summit, visit the Summit website here.
About BioForward
BioForward Wisconsin is the collective voice of Wisconsins robust and comprehensive biohealth cluster, which represents more than 220 member organizations across an integrated network of health solution leaders, including research institutions, biotech and biopharma, digital health and medical device and diagnostics. It is an action-oriented association that focuses on initiatives to strengthen the states talent pipeline; collaborations to develop supply chain partnerships; educational and networking events to enhance professional development; and legislative advocacy to highlight the economic and social impact of the biohealth industry on the state, nation, and world. Learn more about BioForward Wisconsin at http://www.bioforward.org.
Excerpt from:
- Organoids and the future of medicine: from discovery to patient impact - Nature - April 15th, 2025
- Tracking Tissue Development to Inspire Regenerative Therapies - the-scientist.com - April 11th, 2025
- Space Doctors and Stem Cell Production in Microgravity - Cedars-Sinai - April 11th, 2025
- Study aims to stop Alzheimers with stem cell infusions - Drug Target Review - April 11th, 2025
- Why Menstrual Blood May Be 'Goldmine' for Personalized Medicine From Endometriosis to Diabetes and Cancer - Study Finds - April 11th, 2025
- Key Trends Shaping the Future of Stem Cell Assay Market:Innovative Product For Stem Cell Development - WhaTech - April 11th, 2025
- First of its kind stem cell transplant treatment in Boston restores vision to patient - Yahoo - April 8th, 2025
- People are getting costly stem cell injections for knee osteoarthritis, but we don't know if they work - Medical Xpress - April 6th, 2025
- Say goodbye to joint pain without surgery: Expert shares 8 tips on diet plan, lifestyle tweaks, treatments and therapies - Hindustan Times - April 6th, 2025
- Breaking Barriers in Autism: European Wellness Biomedical Group Unveils Bioregenerative Breakthroughs with Prof. Mike Chan -... - April 6th, 2025
- Revolutionizing Success in the Cell Therapy Regenerative - openPR.com - April 4th, 2025
- 5 Best Stem Cell Companies to Invest In (April 2025) - Securities.io - April 4th, 2025
- Boys with cancer can face infertility as adults. Can storing their stem cells help? - Ravalli Republic - April 4th, 2025
- Tip Sheet: Nutrition for People Receiving Stem Cell Transplants, Art Therapy for Cancer Patients, Treating a Rare Type of Colon Cancer and Graduate... - April 4th, 2025
- Human Organoid Market is Set to Revolutionize Drug Discovery and Disease Modeling - openPR.com - April 1st, 2025
- Doctors Told Him He Was Going to Die. Then A.I. Saved His Life. - The New York Times - March 24th, 2025
- Japan team says stem cell treatment helped improve spinal cord injuries | NHK WORLD-JAPAN News - NHK WORLD - March 22nd, 2025
- Boost in cancer treatment: PGI working on lab for stem cell, gene therapies - The Times of India - March 19th, 2025
- Stem Cell Stocks on the Rise: Companies Driving the $48 Billion Market Boom - openPR - March 19th, 2025
- Neuroregeneration Therapy Market Forecasted to Expand at 5.3% CAGR, Reaching USD 64.8 Billion by 2034 - Transparency Market Research, Inc -... - March 19th, 2025
- Cell Therapy Market Surges as Breakthrough Innovations Transform Regenerative Medicine - openPR - March 17th, 2025
- Infinite Health Integrative Medicine Center Fights Chronic Pain with Stem Cell Prolotherapy - PR Newswire - March 14th, 2025
- Stem Cell and Exosome Innovations at Infinite Health Integrative Medicine Center Offers New Hope for Parkinson's Disease - PR Newswire - March 14th, 2025
- Adia Nutrition Hunts for Top Sales Talent to Power Adia Med and Adia Labs Expansion - TradingView - March 14th, 2025
- Cell Therapy Market Poised for Exponential Growth, Projected to Reach USD 44.6 Billion by 2034 - openPR - March 14th, 2025
- Trial Repairs Irreversible Corneal Damage With Stem Cell Therapy - Anti Aging News - March 11th, 2025
- Advancing Regenerative Medicine: A Comprehensive Outlook on the Global Cell Therapy Market - openPR - March 7th, 2025
- Top 3 Grants in Regenerative Medicine: February 2025 - RegMedNet - March 7th, 2025
- The future of cell therapy: scaling production for global reach - Drug Target Review - March 7th, 2025
- Stem Cell Therapy Repairs Corneal Damage in Trial - Mirage News - March 7th, 2025
- Autologous Cell Therapy Market Anticipated to Hit USD 12.1 Billion by 2031: Persistence Market Research Study - openPR - March 7th, 2025
- Regenerative Therapies Market Forecast to Reach USD 24.41 Billion by 2033 - Persistence Market Research - openPR - March 5th, 2025
- This Japanese Regenerative Medicine Company Just Secured Its Path to NASDAQ Through a $242M Deal - StockTitan - March 5th, 2025
- Ryoncil, the first FDA-approved mesenchymal stromal cell therapy - Yahoo - March 5th, 2025
- Animal Stem Cell Therapy Market Forecast to Reach USD 437.3 - openPR - March 3rd, 2025
- A Navy SEALs Journey to Stem Cell Treatment: The Future of Medicine is Here, Just Not in America - SOFREP - March 3rd, 2025
- InnovationRx: Eli Lilly Has Stockpiled Nearly $550 Million Of Its Next Obesity Drug - Forbes - March 3rd, 2025
- VUMC Part of New Study Validating Curative Therapy for Sickle Cell Disease A - Wgnsradio - March 1st, 2025
- Advancing Stem Cell Therapy and Equity in Patient Care - Targeted Oncology - February 27th, 2025
- How Stem Cell Treatment Reversed A Pro Athlete's Life-threatening Long COVID Disease When all Other treatment Failed - Medical Tourism Magazine - February 27th, 2025
- Allogeneic Cell Therapy Market Size to Hit USD 4,677.38 Million by 203 - BioSpace - February 27th, 2025
- Bringing Fibroblasts to the Spotlight: Q&A with FibroBiologics - Pharmaceutical Executive - February 27th, 2025
- Mount Sinai-Led Research Team Identifies Underlying Mechanisms of Age-Related Dysfunction in Glands Crucial to Eye Function | Newswise - Newswise - February 25th, 2025
- Experts explore the future of iPSC-based cell therapies - Drug Target Review - February 19th, 2025
- Longeveron Announces World Health Organization Approval of laromestrocel as International Non-proprietary Name for Stem Cell Therapy Lomecel-B -... - February 19th, 2025
- The impact of cytokines on stem cells and organoid research in drug discovery - News-Medical.Net - February 19th, 2025
- Revolutionary FDA-Approved Stem Cell Partnership Puts Adia Med at Forefront of Regenerative Medicine - StockTitan - February 19th, 2025
- Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US - BioSpace - February 19th, 2025
- Bahrain's pioneering use of sickle cell disease treatment hailed by medical experts - The National - February 19th, 2025
- Uganda Treats First Patient Using Stem Cell Therapy - AllAfrica - Top Africa News - February 19th, 2025
- Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US - StreetInsider.com - February 17th, 2025
- Diversity of Cells Allow Colon Cancer to Resist Treatment and To Metastasize - MedicalResearch.com - February 15th, 2025
- Survival outcomes between haploidentical stem cell transplantation and chemotherapy for blastic plasmacytoid dendritic cell neoplasm - Nature.com - February 13th, 2025
- Experimental cell therapy trial treats first Sjgrens disease patient - University of Wisconsin School of Medicine and Public Health - February 11th, 2025
- Stem Cell Therapy Market Types, Applications, Share, Growth - openPR - February 6th, 2025
- Placental Stem Cell Therapy Solution Market Size And Booming - openPR - February 6th, 2025
- Revitalizing Health with Stem Cell Therapy: A Groundbreaking Path To Longevity and Wellness - openPR - February 4th, 2025
- Gene therapy offers new hope for sickle cell disease patients - Open Access Government - February 4th, 2025
- Scientists trial implant to patch up the heart - BBC.com - February 2nd, 2025
- Cell Therapy Market Size is Projected to Reach USD 33.93 - GlobeNewswire - January 28th, 2025
- Meet the California Institute Pushing Stem Cell & Gene Therapy Research: Part 3 - The Medicine Maker - January 28th, 2025
- Immusoft to Present Positive Data from the First Engineered B Cell in a Human Clinical Trial at the 21st Annual WorldSymposium 2025 - The Eastern... - January 28th, 2025
- Beyond the Lab: Stem cell research - Drug Target Review - January 25th, 2025
- Asia Pacific Stem Cell Therapy Market to Reach US$ 4,075.75 Million by 2033 with a Robust CAGR of 10.29% - openPR - January 25th, 2025
- Exciting data: S.Biomedics preps US IND of PD cell therapy - BioWorld Online - January 25th, 2025
- $24.85 Billion Cell Therapy Market Forecast by 2032 (CAGR 20.4%) - openPR - January 25th, 2025
- Stem Cell Therapy Market Expected to Expand at a Steady 2025-2032 - openPR - January 25th, 2025
- Regenerative Medicine Market to receive overwhelming hike US$ 164.9 billion in Revenues by 2032, Growing at a CAGR of 23.30% From 2024 to 2032 -... - January 25th, 2025
- Alternative medicine fans see RFK Jr. as a hero. The fields skeptics worry. - The Washington Post - January 23rd, 2025
- U.S. PRP and Stem Cell Alopecia Treatment Market Analysis 2025-2030 by Treatment, Indication, and End-use - Androgenic Alopecia Dominated the Market... - January 23rd, 2025
- The Future of Regenerative Medicine Lies in the Hands of Chiropractors - Dynamic Chiropractic - January 23rd, 2025
- Stem Cell Therapy Industry Dynamics and Contributions by RTI - openPR - January 21st, 2025
- Stem Cells Market to Reach USD 44.27 Billion by 2033, Driven by Expanding Applications and Innovations - openPR - January 21st, 2025
- Organoids at the Forefront Innovations in Stem Cell Research and Precision Medicine - openPR - January 21st, 2025
- The promising future of regenerative medicine - Yahoo Finance - January 17th, 2025
- An earful of gill: USC Stem Cell study points to the evolutionary origin of the mammalian outer ear - EurekAlert - January 11th, 2025
- Aspen Partners with Mytos to Automate Stem Cell Production for Parkinsons Therapy - Genetic Engineering & Biotechnology News - January 9th, 2025
- School of Medicine professor receives grant to study improved cancer treatments - Mercer University - January 9th, 2025
- Meet CIRM: the California Institute Pushing Stem Cell and Gene Therapy Research: Part 1 - The Medicine Maker - January 7th, 2025
- Regenerative Medicine Market to Experience Significant Growth, Projected to Reach $183.08 Billion by 2031. - openPR - January 7th, 2025
Recent Comments